Another study noted that sacubitril/valsartan in patients with CHF and atrial fibrillation leads to a significant decrease in the level of brain natriuretic peptide and showed a clear trend towards reversing myocardial remodeling ( 21 ).
1
—
—
Another study noted that sacubitril/valsartan in patients with CHF and atrial fibrillation leads to a significant decrease in the level of brain natriuretic peptide and showed a clear trend towards reversing myocardial remodeling ( 21 ).